Research and Markets (http://www.researchandmarkets.com/research/7mmwh2/head_and_neck) has announced the addition of the "Head And Neck Cancer Squamous Cell Carcinoma-Pipeline Insights, 2016" report to their offering.
Head And Neck Cancer Squamous Cell Carcinoma-Pipeline Insights, 2016 provides in depth insights on the pipeline drugs and their development activities around the Head And Neck Cancer Squamous Cell Carcinoma. The report covers the product profiles in various stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration.
Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & EMA designations details.
The report also provides detailed information on the discontinued and dormant drugs that have gone inactive over the years for Head And Neck Cancer Squamous Cell Carcinoma.
The report also assesses the Head And Neck Cancer Squamous Cell Carcinoma therapeutics by Monotherapy, Combination products, molecule type and Route of Administration.
Scope
- The report provides competitive pipeline landscape of Head And Neck Cancer Squamous Cell Carcinoma
- The report provides pipeline products under drug profile section which includes product description, MOA, licensors & collaborators, development partner and chemical information
- Coverage of the Head And Neck Cancer Squamous Cell Carcinoma pipeline on the basis of target, MOA, route of administration, technology involved and molecule type
- The report reviews key players involved in the therapeutics development for Head And Neck Cancer Squamous Cell Carcinoma and also provide company profiling
- The report also gives the information of dormant and discontinued pipeline projects
- Pipeline products coverage based on various stages of development ranging from preregistration till discovery and undisclosed stages
- Provides pipeline assessment by monotherapy and combination therapy products, stage of development and molecule type
Key Topics Covered:
- Head And Neck Cancer Squamous Cell Carcinoma Overview
- Head And Neck Cancer Squamous Cell Carcinoma Pipeline Therapeutics
- Head And Neck Cancer Squamous Cell Carcinoma Therapeutics under Development by Companies
- Head And Neck Cancer Squamous Cell Carcinoma Filed and Phase III Products
- Comparative Analysis
- Head And Neck Cancer Squamous Cell Carcinoma Phase II Products
- Comparative Analysis
- Head And Neck Cancer Squamous Cell Carcinoma Phase I and IND Filed Products
- Comparative Analysis
- Head And Neck Cancer Squamous Cell Carcinoma Discovery and Pre-Clinical Stage Products
- Comparative Analysis
- Drug Candidate Profiles
- Head And Neck Cancer Squamous Cell Carcinoma - Therapeutics Assessment
- Assessment by Monotherapy Products
- Assessment by Combination Products
- Assessment by Route of Administration
- Assessment by Molecule Type
- Head And Neck Cancer Squamous Cell Carcinoma - Discontinued Products
- Head And Neck Cancer Squamous Cell Carcinoma - Dormant Products
- Companies Involved in Therapeutics Development for Head And Neck Cancer Squamous Cell Carcinoma
For more information visit http://www.researchandmarkets.com/research/7mmwh2/head_and_neck
View source version on businesswire.com: http://www.businesswire.com/news/home/20160113005605/en/
